CELA1: A Potential Drug Target and Biomarker (G1990)

Target Name: CELA1

NCBI ID: G1990

CELA1

CELA1: A Potential Drug Target and Biomarker

CELA1 (Cytokine-Induced Enhanced LDH (Leucine) Degrading) is a protein that is expressed in various tissues and cells in the body. It is a cytokine, which is a protein that is produced by cells in response to the presence of other cells or factors. CELA1 has been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation.

One of the unique features of CELA1 is its ability to induce the production of intracellular leucine, which is a protein that is involved in the detoxification of harmful substances. This production of leucine is thought to contribute to CELA1's potential as a drug target.

CELA1 has been shown to interact with several different proteins, including the transcription factor NF-kappa-B. This interaction between CELA1 and NF-kappa-B suggests that CELA1 may be involved in the regulation of cellular processes that are influenced by NF-kappa-B signaling.

CELA1 has also been shown to be involved in the regulation of cellular apoptosis. When cells are exposed to environmental stressors, such as UV radiation or certain chemicals, CELA1 has been shown to induce apoptosis. This process is thought to be an important part of the cell's response to stress and ensure the survival of the cell.

Another potential role of CELA1 is as a biomarker for certain diseases. For example, CELA1 has been shown to be elevated in the blood of individuals with certain types of cancer, such as breast cancer. This increase in CELA1 levels may be a sign of the presence of cancer cells in the body, making CELA1 a potential biomarker for cancer.

In addition to its potential as a drug target and biomarker, CELA1 is also of interest to researchers because of its unique structure and mechanism of action. CELA1 is a cytokine that is produced by cells in response to the presence of other cells or factors. This means that CELA1 has a specific function in the body and is produced in response to specific stimuli. This focus on specificity and regulation makes CELA1 a unique protein that is worth studying.

Overall, CELA1 is a protein that has the potential to be a drug target and biomarker. Its unique structure and mechanism of action, as well as its ability to induce the production of intracellular leucine, make it an intriguing protein that is worth further research. Further studies may be able to determine the full range of functions that CELA1 has in the body and its potential as a drug.

Protein Name: Chymotrypsin Like Elastase 1

Functions: Acts upon elastin

The "CELA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CELA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets